Literature DB >> 1839572

Laparoscopic cholecystectomy in anticoagulated patients.

S D Fitzgerald1, P V Bailey, G J Liebscher, C H Andrus.   

Abstract

Although minimally surgically invasive, laparoscopic surgery has yet to be proven safe in patients receiving anticoagulants. Retrospectively, the laparoscopic management of four patients requiring anticoagulation for cardiac valvular prostheses or chronic atrial fibrillation was reviewed with regard to potential hemorrhagic complications. Warfarin was discontinued preoperatively in all cases. Heparin anticoagulation was individualized according to each patient's risk for thrombosis. Laparoscopic cholecystectomy and intraoperative cholangiography were completed in each patient without resulting hemorrhagic complications. The operative management of patients exhibiting cholecystitis may be complicated by anticoagulation therapy required for preexisting conditions/diseases such as cardiac valve prostheses, chronic atrial fibrillation, deep venous thrombosis, and pulmonary embolism. The minimally invasive nature of laparoscopic surgery lends itself well to cholecystectomy required in the face of anticoagulation treatment. This limited initial series of selected patients demonstrates the feasibility and efficacy of laparoscopic cholecystectomy in patients receiving anticoagulants.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1839572     DOI: 10.1007/bf02653254

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  5 in total

Review 1.  Perioperative anticoagulant control.

Authors:  S Travis; R Wray; K Harrison
Journal:  Br J Surg       Date:  1989-11       Impact factor: 6.939

2.  Cystic duct cholangiography during laparoscopic cholecystectomy.

Authors:  M E Blatner; C M Wittgen; C H Andrus; D L Kaminski
Journal:  Arch Surg       Date:  1991-05

3.  Living with prosthetic heart valves. Subsequent noncardiac operations and the risk of thromboembolism or hemorrhage.

Authors:  R E Katholi; S P Nolan; L B McGuire
Journal:  Am Heart J       Date:  1976-08       Impact factor: 4.749

4.  Management of patients with heart disease for noncardiac surgery.

Authors:  J H Tinker; C R Noback; R E Vlietstra; R L Frye
Journal:  JAMA       Date:  1981-09-18       Impact factor: 56.272

5.  Discontinuing anticoagulant therapy in surgical patients with cardiac valve prostheses. Observations in 180 operations.

Authors:  J H Tinker; S Tarhan
Journal:  JAMA       Date:  1978-02-20       Impact factor: 56.272

  5 in total
  6 in total

Review 1.  Perioperative management of the chronically anticoagulated patient.

Authors:  J A Heit
Journal:  J Thromb Thrombolysis       Date:  2001-09       Impact factor: 2.300

2.  Laparoscopic surgery. Mistakes and risks when the method is introduced.

Authors:  H Niebuhr; U Nahrstedt; K Rückert; S Hollmann
Journal:  Surg Endosc       Date:  1993 Sep-Oct       Impact factor: 4.584

3.  Laparoscopic cholecystectomy.

Authors:  K E Hobbs
Journal:  Gut       Date:  1995-02       Impact factor: 23.059

4.  Laparoscopic cholecystectomy in patients undergoing anticoagulant therapy.

Authors:  T Yoshida; S Kitano; T Matsumoto; T Bandoh; D Baatar; K Ninomiya; T Hadama
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

5.  Postoperative hemorrhagic complications after elective laparoscopic cholecystectomy in patients receiving long-term anticoagulant therapy.

Authors:  Metin Ercan; Erdal B Bostanci; Ilter Ozer; Murat Ulas; Yusuf B Ozogul; Zafer Teke; Musa Akoglu
Journal:  Langenbecks Arch Surg       Date:  2009-03-18       Impact factor: 3.445

6.  Predictive Factors for a Long Hospital Stay in Patients Undergoing Laparoscopic Cholecystectomy.

Authors:  Wasana Ko-Iam; Trichak Sandhu; Sahattaya Paiboonworachat; Paisal Pongchairerks; Anon Chotirosniramit; Narain Chotirosniramit; Kamtone Chandacham; Tidarat Jirapongcharoenlap; Sunhawit Junrungsee
Journal:  Int J Hepatol       Date:  2017-01-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.